I agree that this site is using cookies. You can find further informations here.
X
Rozeman, Elisa A
51  results:
Search for persons X
?
1

IMPemBra: a phase 2 study comparing pembrolizumab with inte..:

Rozeman, Elisa A ; Versluis, Judith M ; Sikorska, Karolina...
Journal for ImmunoTherapy of Cancer.  11 (2023)  7 - p. e006821 , 2023
Link: https://doi.org/10.1136/..
 
?
2

Systemic LRG1 Expression in Melanoma is Associated with Dis..:

Hoefsmit, Esmee P. ; Völlmy, Franziska ; Rozeman, Elisa A....
Cancer Research Communications.  3 (2023)  4 - p. 672-683 , 2023
Link: https://doi.org/10.1158/..
 
?
3

Author Correction: Reversal of pre-existing NGFR-driven tum..:

Boshuizen, Julia ; Vredevoogd, David W. ; Krijgsman, Oscar...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
4

Personalizing neoadjuvant immune-checkpoint inhibition in p..:

Lucas, Minke W. ; Versluis, Judith M. ; Rozeman, Elisa A..
Nature Reviews Clinical Oncology.  , 2023
Link: https://doi.org/10.1038/..
 
?
5

Personalized response-directed surgery and adjuvant therapy..:

Reijers, Irene L. M. ; Menzies, Alexander M. ; van Akkooi, Alexander C. J....
Nature Medicine.  28 (2022)  6 - p. 1178-1188 , 2022
Link: https://doi.org/10.1038/..
 
?
6

Chemotherapy after immune checkpoint inhibitor failure in m..:

Goldinger, Simone M. ; Buder-Bakhaya, Kristina ; Lo, Serigne N....
European Journal of Cancer.  162 (2022)  - p. 22-33 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Diagnostic performance of early increase in S100B or LDH as..:

Rozeman, Elisa A. ; Versluis, Judith M. ; Moritz, Ruben...
Clinica Chimica Acta.  533 (2022)  - p. 71-78 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Neoadjuvant ipilimumab plus nivolumab in synchronous clinic..:

Versluis, Judith M. ; Reijers, Irene L.M. ; Rozeman, Elisa A....
European Journal of Cancer.  148 (2021)  - p. 51-57 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Pathological response and survival with neoadjuvant therapy..:

Menzies, Alexander M. ; Amaria, Rodabe N. ; Rozeman, Elisa A....
Nature Medicine.  27 (2021)  2 - p. 301-309 , 2021
Link: https://doi.org/10.1038/..
 
?
10

Differential effects of PD-1 and CTLA-4 blockade on the mel..:

Gangaev, Anastasia ; Rozeman, Elisa A. ; Rohaan, Maartje W....
Proceedings of the National Academy of Sciences.  118 (2021)  43 - p. , 2021
Link: https://doi.org/10.1073/..
 
?
11

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically..:

Li, Hanjie ; van der Leun, Anne M. ; Yofe, Ido...
Cell.  181 (2020)  3 - p. 747 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Comprehensive analysis of cutaneous and uveal melanoma live..:

Hoefsmit, Esmee P ; Rozeman, Elisa A ; Van, Trieu My...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e001501 , 2020
Link: https://doi.org/10.1136/..
 
?
13

Reversal of pre-existing NGFR-driven tumor and immune thera..:

Boshuizen, Julia ; Vredevoogd, David W. ; Krijgsman, Oscar...
Nature Communications.  11 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
14

First-line therapy-stratified survival in BRAF-mutant melan..:

Schilling, Bastian ; Martens, Alexander ; Geukes Foppen, Marnix H....
Cancer Immunology, Immunotherapy.  68 (2019)  5 - p. 765-772 , 2019
Link: https://doi.org/10.1007/..
 
?
15

Susceptible loci associated with autoimmune disease as pote..:

Hoefsmit, Esmée P. ; Rozeman, Elisa A. ; Haanen, John B.A.G..
ESMO Open.  4 (2019)  4 - p. e000472 , 2019
Link: https://doi.org/10.1136/..
 
1-15